| 3sbio Inc | SSRX | United States | 0.04 | 26 | 5 | 5 | 12 | 11 | 50.00 % | 45.83 % | 2 |
| Aastrom Biosciences Inc | ASTM | United States | -0.20 | 37 | 4 | 8 | 9 | 12 | 25.71 % | 34.28 % | 2 |
| Abraxis Bioscience Inc | ABII | United States | -0.19 | 94 | 9 | 13 | 27 | 38 | 35.52 % | 50.00 % | 18 |
| Acorda Therapeutics Inc | ACOR | United States | 0.42 | 146 | 23 | 9 | 68 | 34 | 59.64 % | 29.82 % | 32 |
| Advanced Cell Technology Inc | ACTC.PK | United States | 0.66 | 3 | 1 | 0 | 1 | 0 | 33.33 % | 0.00 % | 0 |
| Advanced Tissue Sciences Inc | ATISZ.PK | United States | 0.50 | 2 | 1 | 0 | 1 | 1 | 50.00 % | 50.00 % | 0 |
| Adventrx Pharmaceuticals Inc | ANX | United States | -0.10 | 30 | 4 | 3 | 6 | 10 | 20.68 % | 34.48 % | 1 |
| Aeterna Zentaris Inc | AEZS | Canada | 0.26 | 19 | 4 | 3 | 9 | 5 | 47.36 % | 26.31 % | 0 |
| Aethlon Med Inc | AEMD.PK | United States | 2.00 | 1 | 1 | 0 | 1 | 0 | 100.00 % | 0.00 % | 0 |
| Affymax Inc | AFFY | United States | 0.49 | 70 | 15 | 4 | 33 | 15 | 55.93 % | 25.42 % | 11 |
| Affymetrix Inc | AFFX | United States | 0.43 | 90 | 11 | 3 | 28 | 15 | 58.33 % | 31.25 % | 42 |
| Aksys Ltd | AKSY.PK | United States | 0.00 | 1 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Alexion Pharmaceuticals Inc | ALXN | United States | 0.30 | 283 | 46 | 15 | 116 | 80 | 53.21 % | 36.69 % | 65 |
| Amag | AMAG | Belgium | | | | | | | % | % | 1 |
| Amag Pharmaceuticals Inc | AMU.BE | United States | 0.36 | 167 | 25 | 14 | 76 | 39 | 57.57 % | 29.54 % | 35 |
| Amarillo Biosciences Inc | AMAR.PK | United States | 0.00 | 1 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Ambrilia Biopharma Inc | AMBFF.PK | Canada | | | | | | | % | % | 2 |
| American Bio Medica Corp | ABMC | United States | -0.27 | 11 | 0 | 0 | 2 | 5 | 18.18 % | 45.45 % | 0 |
| American Oriental Bioengi ... | RXZ.BE | United States | -0.03 | 183 | 25 | 29 | 71 | 73 | 44.65 % | 45.91 % | 24 |
| Amgen Inc | AMGN | United States | -0.15 | 1196 | 85 | 99 | 357 | 490 | 37.26 % | 51.14 % | 238 |
| Anesiva Inc | ANSV | United States | -0.48 | 38 | 4 | 11 | 7 | 16 | 21.21 % | 48.48 % | 5 |
| Aphton Corp | APHTQ.PK | United States | -1.00 | 2 | 0 | 1 | 0 | 1 | 0.00 % | 50.00 % | 0 |
| Applera Corp | CRA | United States | -0.37 | 403 | 50 | 103 | 120 | 193 | 35.82 % | 57.61 % | 68 |
| Arana Therapeutics Limited | ATPCF.PK | Australia | 0.00 | 1 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Arena Pharmaceuticals Inc | ARNA | United States | 0.22 | 148 | 22 | 19 | 69 | 43 | 53.48 % | 33.33 % | 19 |
| Ariad Pharmaceuticals Inc | ARIA | United States | -0.01 | 117 | 9 | 18 | 46 | 38 | 46.46 % | 38.38 % | 18 |
| Ark Therapeutics Group | TXF.BE | United Kingdom | -2.00 | 1 | 0 | 1 | 0 | 1 | 0.00 % | 100.00 % | 0 |
| Arqule Inc | ARQL | United States | 0.28 | 120 | 19 | 13 | 53 | 31 | 53.53 % | 31.31 % | 21 |
| Aryx Therapeutics | ARYX | United States | 0.00 | 20 | 2 | 1 | 5 | 6 | 31.25 % | 37.50 % | 4 |
| Aspenbio Pharma Inc | AP4.BE | United States | 0.30 | 44 | 12 | 9 | 23 | 13 | 53.48 % | 30.23 % | 1 |
| Athersys Inc | ATHX | United States | 0.36 | 14 | 2 | 2 | 6 | 2 | 54.54 % | 18.18 % | 3 |
| Autoimmune Inc | AIMM.PK | United States | -0.33 | 7 | 0 | 1 | 0 | 1 | 0.00 % | 16.66 % | 1 |
| Avant Immunotherapeutics Inc | AVAN | United States | -0.42 | 8 | 2 | 2 | 2 | 5 | 28.57 % | 71.42 % | 1 |
| Avigen Inc | AVGN | United States | 0.14 | 45 | 5 | 5 | 16 | 10 | 39.02 % | 24.39 % | 4 |
| Bachem Holding Ag | BHM.BE | Switzerland | | | | | | | % | % | 2 |
| Barrier Therapeutics Inc | BTRX | United States | 0.00 | 68 | 18 | 17 | 25 | 26 | 42.37 % | 44.06 % | 9 |
| Basilea Pharmaceutica Ag | PK5.BE | Switzerland | 0.22 | 17 | 3 | 2 | 4 | 3 | 44.44 % | 33.33 % | 8 |
| Bio Rad Laboratories Inc | BIO | United States | 0.25 | 4 | 1 | 1 | 2 | 1 | 50.00 % | 25.00 % | 0 |
| Biocryst Pharmaceuticals Inc | BCRX | United States | -0.19 | 72 | 6 | 13 | 21 | 27 | 31.81 % | 40.90 % | 6 |
| Biodelivery Sciences Intl ... | BDSI | United States | -0.55 | 9 | 0 | 2 | 1 | 4 | 11.11 % | 44.44 % | 0 |
| Biogen Idec Inc | BIIB | United States | 0.13 | 655 | 73 | 62 | 255 | 198 | 48.85 % | 37.93 % | 133 |
| Biomimetic Therapeutics Inc | BMTI | United States | 0.24 | 100 | 18 | 13 | 43 | 28 | 53.08 % | 34.56 % | 19 |
| Bioms Medical Corp | BOMSF.PK | Canada | 0.50 | 3 | 0 | 0 | 1 | 0 | 50.00 % | 0.00 % | 1 |
| Bioniche Life Sciences Inc | BNHLF.PK | Canada | | | | | | | % | % | 1 |
| Biosante Pharmaceuticals Inc | BPAX | United States | 0.24 | 28 | 3 | 3 | 12 | 6 | 48.00 % | 24.00 % | 3 |
| Biosphere Med Inc | BSMD | United States | -0.10 | 30 | 1 | 5 | 10 | 9 | 34.48 % | 31.03 % | 1 |
| Biotest Ag | BIO.BE | Germany | 1.00 | 1 | 0 | 0 | 1 | 0 | 100.00 % | 0.00 % | 0 |
| Biotime Inc | BTIMW.PK | United States | 0.00 | 1 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Bioton Sa | BIO.WA | Poland | 0.00 | 5 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 2 |
| Callisto Pharmaceuticals Inc | KAL | United States | -0.25 | 8 | 0 | 1 | 1 | 2 | 12.50 % | 25.00 % | 0 |
| Cambrex Corp | CBM | United States | 0.06 | 147 | 15 | 16 | 56 | 48 | 48.27 % | 41.37 % | 31 |
| Cangene Corporation | CGNOF.PK | Canada | 0.00 | 2 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 1 |
| Cardium Therapeutics Inc | 42C.BE | United States | 0.07 | 13 | 3 | 3 | 6 | 5 | 46.15 % | 38.46 % | 0 |
| Celgene Corp | CELG | United States | 0.14 | 838 | 90 | 68 | 333 | 259 | 50.37 % | 39.18 % | 177 |
| Cell Genesys Inc | CEGE | United States | 0.32 | 118 | 18 | 10 | 56 | 31 | 54.36 % | 30.09 % | 15 |
| Cell Therapeutics Inc | CTIC | United States | 1.00 | 6 | 2 | 0 | 2 | 0 | 50.00 % | 0.00 % | 2 |
| Cellcyte Genetics Corp | CCYG.PK | United States | 0.00 | 1 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Cellegy Pharmaceuticals Inc | CLGY.PK | United States | -2.00 | 2 | 0 | 2 | 0 | 2 | 0.00 % | 100.00 % | 0 |
| Cellestis Limited | CLLWF.PK | Australia | 0.00 | 5 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 4 |
| Charles River Laboratorie ... | CRL | United States | 0.03 | 420 | 47 | 45 | 162 | 151 | 46.28 % | 43.14 % | 70 |
| Chemeq Limited | CMG.BE | Australia | | | | | | | % | % | 3 |
| Chemgenex Pharmaceuticals ... | ABU.BE | Australia | | | | | | | % | % | 4 |
| Chemokine Therapeutics Corp | CHKT.PK | United States | 0.00 | 2 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| China Biologic Prods Inc | CBPO.PK | United States | 1.00 | 1 | 0 | 0 | 1 | 0 | 100.00 % | 0.00 % | 0 |
| China Biotics Inc | D8R.BE | United States | 1.00 | 1 | 0 | 0 | 1 | 0 | 100.00 % | 0.00 % | 0 |
| China Mining Resources Gr ... | CXGUF.PK | Bermuda | | | | | | | % | % | 1 |
| Chubu Electric Power Comp ... | CEP.IL | Japan | 1.00 | 7 | 2 | 0 | 3 | 1 | 75.00 % | 25.00 % | 3 |
| Cleveland Biolabs Inc | CBLI | United States | 0.26 | 19 | 6 | 5 | 11 | 7 | 57.89 % | 36.84 % | 0 |
| Clinical Data Inc | CLDA | United States | 0.21 | 65 | 16 | 10 | 27 | 21 | 47.36 % | 36.84 % | 8 |
| Coley Pharmaceutical Grou ... | COLY | United States | -2.00 | 5 | 0 | 5 | 0 | 5 | 0.00 % | 100.00 % | 0 |
| Combimatrix Corp | 44C.BE | United States | 0.18 | 22 | 6 | 4 | 10 | 8 | 45.45 % | 36.36 % | 0 |
| Conjuchem Biotechnologies ... | CJBFF.PK | Canada | | | | | | | % | % | 1 |
| Cougar Biotechnology Inc | CGRB | United States | 0.74 | 83 | 28 | 6 | 43 | 15 | 64.17 % | 22.38 % | 16 |
| Crucell N V | CRXL | United States | 0.03 | 33 | 6 | 4 | 13 | 14 | 39.39 % | 42.42 % | 0 |
| Cryolife Inc | CYL.BE | United States | 0.46 | 142 | 30 | 10 | 70 | 34 | 58.33 % | 28.33 % | 22 |
| Csl Ltd | CMXHF.PK | Australia | 0.74 | 75 | 15 | 4 | 19 | 7 | 61.29 % | 22.58 % | 44 |
| Curagen Corp | CRGN | United States | 0.36 | 51 | 9 | 3 | 21 | 10 | 45.65 % | 21.73 % | 5 |
| Curis Inc | CRIS | United States | 0.22 | 56 | 8 | 2 | 19 | 14 | 38.77 % | 28.57 % | 7 |
| Cytogen Corp | CYTO | United States | -1.54 | 38 | 2 | 31 | 3 | 31 | 8.10 % | 83.78 % | 1 |
| Cytogenix Inc | CYQ.BE | United States | 0.00 | 1 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Cytokinetics Inc | CYTK | United States | 0.28 | 77 | 7 | 2 | 34 | 20 | 51.51 % | 30.30 % | 11 |
| Cytopia Limited | CYTPF.PK | Australia | | | | | | | % | % | 2 |
| Cytori Therapeutics Inc | XMPA.BE | United States | 1.07 | 57 | 26 | 1 | 41 | 8 | 75.92 % | 14.81 % | 3 |
| Decode Genetics Inc | DCGN | United States | -0.58 | 72 | 4 | 16 | 9 | 30 | 16.07 % | 53.57 % | 16 |
| Deltagen Inc | DGEN.PK | United States | 0.00 | 1 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Dnaprint Genomics Inc | DNAG.PK | United States | 2.00 | 1 | 1 | 0 | 1 | 0 | 100.00 % | 0.00 % | 0 |
| Dyadic Intl Inc | DYAI.PK | United States | -0.50 | 6 | 0 | 0 | 0 | 3 | 0.00 % | 50.00 % | 0 |
| Encysive Pharmaceuticals Inc | TB3.BE | United States | -1.64 | 78 | 2 | 58 | 4 | 60 | 5.88 % | 88.23 % | 10 |
| Entremed Inc | ENMD | United States | 0.00 | 38 | 4 | 5 | 11 | 10 | 29.72 % | 27.02 % | 1 |
| Enzo Biochem Inc | ENZ | United States | 0.22 | 123 | 10 | 10 | 52 | 30 | 52.00 % | 30.00 % | 23 |
| Enzon Inc | ENZN | United States | 2.00 | 6 | 5 | 0 | 5 | 0 | 100.00 % | 0.00 % | 1 |
| Enzon Pharmaceuticals Inc | EZ1.BE | United States | 0.09 | 169 | 21 | 16 | 63 | 55 | 44.05 % | 38.46 % | 26 |
| Exact Sciences Corp | EXAS | United States | 0.02 | 37 | 4 | 4 | 11 | 10 | 29.72 % | 27.02 % | 0 |
| Exelixis Inc | EXEL | United States | -0.14 | 186 | 10 | 22 | 52 | 61 | 35.86 % | 42.06 % | 41 |
| Genaera Corp | GENR | United States | 0.07 | 26 | 3 | 1 | 6 | 6 | 23.07 % | 23.07 % | 0 |
| Genelabs Technologies Inc | GNLB | United States | 0.11 | 35 | 5 | 5 | 14 | 10 | 40.00 % | 28.57 % | 0 |
| Genentech Inc | DNA | United States | 0.11 | 973 | 99 | 74 | 383 | 315 | 48.54 % | 39.92 % | 184 |
| Genetic Technologies Limited | GENE | Australia | 1.00 | 1 | 0 | 0 | 1 | 0 | 100.00 % | 0.00 % | 0 |
| Genitope Corp | GTOP | United States | -0.33 | 41 | 5 | 9 | 10 | 19 | 25.64 % | 48.71 % | 2 |
| Genmab A S | GNMSF.PK | Denmark | 0.00 | 2 | 1 | 1 | 1 | 1 | 50.00 % | 50.00 % | 0 |
| Genomed Inc | GMED.PK | United States | 0.00 | 2 | 1 | 1 | 1 | 1 | 50.00 % | 50.00 % | 0 |
| Genomic Health Inc | GHDX | United States | 0.08 | 116 | 13 | 15 | 47 | 37 | 48.95 % | 38.54 % | 20 |
| Genta Inc | GNTA | United States | -1.19 | 28 | 2 | 17 | 3 | 19 | 11.53 % | 73.07 % | 2 |
| Genvec Inc | GNVC | United States | 0.01 | 68 | 11 | 9 | 24 | 25 | 40.67 % | 42.37 % | 9 |
| Genzyme Corp | GENZ | United States | 0.09 | 900 | 82 | 67 | 333 | 284 | 47.50 % | 40.51 % | 199 |
| Geron Corp | GERN | United States | 0.19 | 119 | 14 | 12 | 50 | 32 | 47.61 % | 30.47 % | 14 |
| Glycogenesys Inc | GLGSQ.PK | United States | 2.00 | 1 | 1 | 0 | 1 | 0 | 100.00 % | 0.00 % | 0 |
| Gpc Biotech Ag | GPCBF.PK | Germany | 0.00 | 1 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Gtc Biotherapeutics Inc | GZ2.BE | United States | 0.22 | 33 | 5 | 2 | 10 | 6 | 32.25 % | 19.35 % | 2 |
| Gtx Inc | GTXI | United States | 0.21 | 99 | 11 | 9 | 39 | 25 | 51.31 % | 32.89 % | 23 |
| Halozyme Therapeutics Inc | HALO | United States | 0.10 | 90 | 9 | 9 | 36 | 28 | 45.56 % | 35.44 % | 11 |
| Hana Biosciences Inc | HNAB | United States | 0.21 | 32 | 7 | 4 | 12 | 8 | 37.50 % | 25.00 % | 0 |
| Harvard Bioscience Inc | HBIO | United States | 0.21 | 67 | 7 | 5 | 26 | 16 | 45.61 % | 28.07 % | 10 |
| Health Discovery Corp | HDVY.PK | United States | 0.00 | 2 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Hemobiotech Inc | HMBT | United States | -2.00 | 1 | 0 | 1 | 0 | 1 | 0.00 % | 100.00 % | 0 |
| Human Genome Sciences Inc | HGSI | United States | 0.10 | 210 | 25 | 18 | 80 | 69 | 44.94 % | 38.76 % | 32 |
| Idera Pharmaceuticals Inc | IDRA | United States | 1.11 | 46 | 23 | 1 | 31 | 6 | 73.80 % | 14.28 % | 4 |
| Idm Pharma Inc | IDMI | United States | -0.05 | 17 | 1 | 3 | 6 | 5 | 35.29 % | 29.41 % | 0 |
| Illumina Inc | ILMN | United States | 0.00 | 443 | 60 | 44 | 152 | 171 | 43.30 % | 48.71 % | 92 |
| Immucell Corp | ICCC | United States | 0.00 | 6 | 1 | 1 | 1 | 1 | 16.66 % | 16.66 % | 0 |
| Immunogen Inc | IMGN | United States | 0.58 | 85 | 25 | 3 | 41 | 16 | 51.25 % | 20.00 % | 5 |
| Immunomedics Inc | IMMU | United States | 0.32 | 86 | 13 | 9 | 38 | 18 | 52.05 % | 24.65 % | 13 |
| Imugene Limited | IUGNF.PK | Australia | | | | | | | % | % | 2 |
| Incyte Corp | INCY | United States | -0.05 | 193 | 27 | 31 | 70 | 75 | 41.91 % | 44.91 % | 26 |
| Inhibitex Inc | INHX | United States | 0.09 | 25 | 2 | 1 | 6 | 5 | 27.27 % | 22.72 % | 3 |
| Inovio Biomedical Corp | INO | United States | 0.15 | 19 | 4 | 2 | 6 | 5 | 31.57 % | 26.31 % | 0 |
| Integra Lifesciences Hldg ... | IART | United States | 0.15 | 186 | 21 | 21 | 82 | 57 | 50.61 % | 35.18 % | 24 |
| Intercell Ag | INRLF.PK | Germany | 1.00 | 5 | 1 | 0 | 1 | 0 | 50.00 % | 0.00 % | 3 |
| Intermune Inc | ITMN | United States | 0.20 | 156 | 25 | 12 | 61 | 48 | 49.19 % | 38.70 % | 32 |
| Invitrogen Corp | IVGN | United States | 0.53 | 525 | 66 | 51 | 288 | 93 | 72.91 % | 23.54 % | 130 |
| Iomai Corp | IOMI | United States | 0.97 | 37 | 20 | 6 | 25 | 6 | 73.52 % | 17.64 % | 3 |
| Keryx Biopharmaceuticals Inc | KERX | United States | -0.43 | 101 | 9 | 21 | 20 | 44 | 24.09 % | 53.01 % | 18 |
| Kosan Biosciences Inc | KOSN | United States | -1.30 | 84 | 5 | 52 | 8 | 59 | 10.66 % | 78.66 % | 9 |
| Lexicon Pharmaceuticals Inc | LXRX | United States | 0.45 | 88 | 22 | 8 | 40 | 19 | 51.94 % | 24.67 % | 11 |
| Lifecell Corp | LIFC | United States | -1.53 | 315 | 10 | 211 | 27 | 226 | 10.34 % | 86.59 % | 54 |
| Lipid Sciences Inc | LIPD | United States | 0.04 | 25 | 2 | 1 | 4 | 4 | 18.18 % | 18.18 % | 3 |
| Lorus Therapeutics Inc | LRP | Canada | -0.50 | 10 | 0 | 1 | 2 | 6 | 20.00 % | 60.00 % | 0 |
| Marshall Edwards Inc | MSHL | United States | 0.66 | 3 | 1 | 0 | 1 | 0 | 33.33 % | 0.00 % | 0 |
| Martek Biosciences Corp | MATK | United States | 0.30 | 312 | 53 | 27 | 141 | 90 | 56.17 % | 35.85 % | 61 |
| Maxygen Inc | MAXY | United States | -0.01 | 95 | 7 | 12 | 35 | 31 | 42.68 % | 37.80 % | 13 |
| Medigene Ag | MDG.BE | Germany | 2.00 | 1 | 1 | 0 | 1 | 0 | 100.00 % | 0.00 % | 0 |
| Medimmune Inc | MDU.BE | United States | -0.66 | 3 | 1 | 2 | 1 | 2 | 33.33 % | 66.66 % | 0 |
| Medivation Inc | MDVN | United States | 0.22 | 105 | 16 | 11 | 47 | 32 | 52.80 % | 35.95 % | 16 |
| Mera Pharmaceuticals Inc | MRPI.PK | United States | 0.50 | 4 | 1 | 0 | 1 | 0 | 25.00 % | 0.00 % | 0 |
| Metabasis Therapeutics Inc | MBRX | United States | 0.13 | 32 | 4 | 4 | 15 | 11 | 50.00 % | 36.66 % | 2 |
| Microislet Inc | MZD.BE | United States | 0.00 | 3 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Micromet Ag | MITI | Germany | 0.28 | 34 | 6 | 4 | 15 | 8 | 46.87 % | 25.00 % | 2 |
| Migenix Inc | MZC.BE | Canada | | | | | | | % | % | 1 |
| Millennium Pharmaceutical ... | MLNM | United States | -1.50 | 358 | 18 | 246 | 36 | 257 | 12.08 % | 86.24 % | 60 |
| Millipore Corp | MIL | United States | 0.02 | 418 | 29 | 31 | 143 | 132 | 42.81 % | 39.52 % | 84 |
| Mingyuan Medicare Develop ... | MGYNF.PK | Bermuda | 2.00 | 2 | 2 | 0 | 2 | 0 | 100.00 % | 0.00 % | 0 |
| Molecular Insightpharmace ... | MIPI | United States | 0.56 | 67 | 14 | 1 | 29 | 10 | 50.87 % | 17.54 % | 10 |
| Momenta Pharmaceuticals Inc | MNTA | United States | 0.58 | 115 | 23 | 8 | 63 | 21 | 64.94 % | 21.64 % | 18 |
| Monogram Biosciences Inc | MGRM | United States | 0.06 | 68 | 7 | 6 | 24 | 21 | 37.50 % | 32.81 % | 4 |
| Morphosys Ag | MOR.BE | Germany | 0.66 | 4 | 1 | 0 | 1 | 0 | 33.33 % | 0.00 % | 1 |
| Myriad Genetics Inc | MYGN | United States | 0.08 | 303 | 49 | 42 | 114 | 101 | 46.15 % | 40.89 % | 56 |
| Nanogen Inc | NGN.BE | United States | -0.08 | 37 | 5 | 5 | 10 | 13 | 27.77 % | 36.11 % | 1 |
| Nanologix Inc | NNLX.PK | United States | 0.00 | 1 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Nanosphere Inc | NSPH | United States | 0.52 | 74 | 19 | 6 | 36 | 17 | 59.01 % | 27.86 % | 13 |
| Nektar Therapeutics | NKTR | United States | -0.06 | 176 | 16 | 30 | 64 | 60 | 42.38 % | 39.73 % | 25 |
| Neogenomics Inc | NG9.F | United States | -1.00 | 1 | 0 | 0 | 0 | 1 | 0.00 % | 100.00 % | 0 |
| Neoprobe Corp | NEOP.PK | United States | 0.00 | 2 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Neose Technologies Inc | NTEC | United States | -0.15 | 45 | 5 | 8 | 10 | 13 | 25.00 % | 32.50 % | 5 |
| Neuro Hitech Inc | NHPI | United States | -1.66 | 6 | 0 | 5 | 0 | 5 | 0.00 % | 83.33 % | 0 |
| Neurobiological Technolog ... | NTII | United States | -0.50 | 2 | 0 | 1 | 1 | 1 | 50.00 % | 50.00 % | 0 |
| Neurochem Inc | NEI.BE | Canada | -1.96 | 28 | 0 | 26 | 0 | 27 | 0.00 % | 100.00 % | 1 |
| Neurogesx Inc | NGSX | United States | -0.45 | 12 | 1 | 4 | 2 | 4 | 18.18 % | 36.36 % | 1 |
| Neurologix Inc | NFE1.BE | United States | 0.00 | 1 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Northfield Laboratories Inc | NFLD | United States | 0.13 | 38 | 4 | 4 | 13 | 8 | 35.13 % | 21.62 % | 1 |
| Novabay Pharmaceuticals Inc | B9P.BE | United States | 0.00 | 13 | 3 | 2 | 4 | 5 | 33.33 % | 41.66 % | 1 |
| Novacea Inc | NOVC | United States | -0.30 | 49 | 7 | 13 | 15 | 22 | 35.71 % | 52.38 % | 7 |
| Novavax Inc | NVAX | United States | 0.60 | 69 | 21 | 4 | 39 | 16 | 59.09 % | 24.24 % | 3 |
| Novelos Therapeutics Inc | NVLT.PK | United States | 2.00 | 1 | 1 | 0 | 1 | 0 | 100.00 % | 0.00 % | 0 |
| Novozymes A S | NVZMF.PK | Denmark | -1.00 | 5 | 0 | 0 | 0 | 2 | 0.00 % | 100.00 % | 3 |
| Nymox Pharmaceutical Corp | NYMX | Canada | -0.50 | 4 | 0 | 1 | 1 | 2 | 25.00 % | 50.00 % | 0 |
| Omrix Biopharmaceuticals Inc | OMRI | United States | 0.05 | 133 | 14 | 12 | 50 | 46 | 45.45 % | 41.81 % | 23 |
| Oncor Inc | ONCR.PK | United States | 0.00 | 1 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Ondine Biopharma Corporation | OBG.BE | Canada | -1.00 | 2 | 0 | 0 | 0 | 1 | 0.00 % | 100.00 % | 1 |
| Opexa Therapeutics Inc | OPXA | United States | 0.16 | 7 | 1 | 0 | 1 | 1 | 16.66 % | 16.66 % | 1 |
| Optimer Pharmaceuticals Inc | OPTR | United States | 0.73 | 49 | 23 | 6 | 29 | 10 | 59.18 % | 20.40 % | 0 |
| Oragenics Inc | ONI | United States | -1.00 | 4 | 0 | 1 | 0 | 3 | 0.00 % | 75.00 % | 0 |
| Orchid Cellmark Inc | ORCH | United States | 0.02 | 54 | 4 | 3 | 15 | 15 | 33.33 % | 33.33 % | 9 |
| Orexigen Therapeutics Inc | OREX | United States | 0.47 | 82 | 16 | 7 | 41 | 18 | 60.29 % | 26.47 % | 14 |
| Oscient Pharmaceuticals Corp | OSCI | United States | 1.25 | 7 | 2 | 0 | 3 | 0 | 75.00 % | 0.00 % | 3 |
| Oxigene Inc | OXGN | United States | 0.20 | 38 | 6 | 4 | 14 | 9 | 41.17 % | 26.47 % | 4 |
| Paion Ag | PAIOF.PK | Germany | -2.00 | 1 | 0 | 1 | 0 | 1 | 0.00 % | 100.00 % | 0 |
| Palatin Technologies Inc | PTN | United States | -0.02 | 37 | 3 | 3 | 8 | 9 | 23.52 % | 26.47 % | 3 |
| Panacos Pharmaceuticals Inc | PANC | United States | -0.12 | 53 | 7 | 9 | 15 | 19 | 31.91 % | 40.42 % | 6 |
| Pdl Biopharma Inc | PDLI | United States | -0.10 | 263 | 34 | 55 | 100 | 103 | 45.04 % | 46.39 % | 41 |
| Peregrine Pharmaceuticals ... | PPHM | United States | -0.08 | 47 | 4 | 3 | 10 | 15 | 21.73 % | 32.60 % | 1 |
| Pharmathene Inc | PIP | United States | 0.25 | 8 | 2 | 1 | 3 | 2 | 37.50 % | 25.00 % | 0 |
| Pipex Pharmaceuticals Inc | PP | United States | -0.70 | 12 | 2 | 4 | 2 | 7 | 20.00 % | 70.00 % | 2 |
| Polymedix Inc | PYMX.PK | United States | 2.00 | 1 | 1 | 0 | 1 | 0 | 100.00 % | 0.00 % | 0 |
| Prana Biotechnology Limited | PRNAF.PK | Australia | 0.00 | 10 | 1 | 1 | 2 | 2 | 28.57 % | 28.57 % | 3 |
| Pressure Biosciences Inc | PBIO | United States | 1.00 | 4 | 0 | 0 | 4 | 0 | 100.00 % | 0.00 % | 0 |
| Protalix Biotherapeutics Inc | PLX | United States | 0.19 | 49 | 8 | 7 | 22 | 15 | 53.65 % | 36.58 % | 8 |
| Protherics | PTS.BE | United Kingdom | 0.00 | 3 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 2 |
| Protokinetix Inc | PKD.BE | United States | -1.00 | 2 | 0 | 1 | 0 | 1 | 0.00 % | 50.00 % | 0 |
| Protox Therapeutics Inc | PTXRF.PK | Canada | 0.00 | 1 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Psivida Ltd | PSDV | United States | -2.00 | 6 | 0 | 6 | 0 | 6 | 0.00 % | 100.00 % | 0 |
| Puricore Plc | PURPF.PK | United Kingdom | 2.00 | 1 | 1 | 0 | 1 | 0 | 100.00 % | 0.00 % | 0 |
| Qiagen N V | QGEN | Germany | -0.21 | 65 | 5 | 5 | 8 | 14 | 28.57 % | 50.00 % | 37 |
| Regeneration Technologies ... | RTIX | United States | -1.56 | 16 | 1 | 13 | 1 | 14 | 6.25 % | 87.50 % | 0 |
| Regeneron Pharmaceuticals ... | REGN | United States | 0.21 | 241 | 34 | 24 | 100 | 69 | 52.35 % | 36.12 % | 50 |
| Regenerx Biopharmaceutica ... | RGN | United States | 0.09 | 11 | 1 | 1 | 4 | 3 | 36.36 % | 27.27 % | 0 |
| Renovo Group | ROVOF.PK | United Kingdom | | | | | | | % | % | 2 |
| Replidyne Inc | RDYN | United States | 0.00 | 23 | 5 | 5 | 7 | 7 | 31.81 % | 31.81 % | 1 |
| Repligen Corp | RGEN | United States | 0.48 | 90 | 21 | 7 | 48 | 22 | 57.83 % | 26.50 % | 7 |
| Response Genetics Inc | RGDX | United States | 0.71 | 7 | 1 | 0 | 5 | 1 | 71.42 % | 14.28 % | 0 |
| Resverlogix Corp | RVXCF.PK | Canada | 1.00 | 3 | 1 | 0 | 1 | 0 | 50.00 % | 0.00 % | 1 |
| Rexahn Pharmaceuticals Inc | RNN | United States | 2.00 | 15 | 15 | 0 | 15 | 0 | 100.00 % | 0.00 % | 0 |
| Rosetta Genomics Ltd | ROSG | United States | 2.00 | 8 | 8 | 0 | 8 | 0 | 100.00 % | 0.00 % | 0 |
| Sangamo Biosciences Inc | SGMO | United States | 0.26 | 129 | 25 | 16 | 57 | 37 | 51.81 % | 33.63 % | 19 |
| Savient Pharmaceuticals Inc | BY7.BE | United States | 0.36 | 231 | 56 | 30 | 115 | 69 | 58.37 % | 35.02 % | 34 |
| Seattle Genetics Inc | SGEN | United States | 0.27 | 168 | 28 | 17 | 70 | 44 | 52.23 % | 32.83 % | 34 |
| Sembiosys Genetics Inc | SMBGF.PK | Canada | | | | | | | % | % | 1 |
| Sequenom Inc | SQNM | United States | 0.60 | 125 | 50 | 20 | 77 | 37 | 66.37 % | 31.89 % | 9 |
| Sgx Pharmaceuticals Inc | SGXP | United States | -0.29 | 17 | 1 | 4 | 6 | 8 | 35.29 % | 47.05 % | 0 |
| Sinovac Biotech Ltd | SVA | Antigua And Barbud ... | -0.11 | 18 | 1 | 5 | 9 | 7 | 50.00 % | 38.88 % | 0 |
| Sonus Pharmaceuticals Inc | SNUS | United States | 0.00 | 29 | 2 | 4 | 9 | 7 | 33.33 % | 25.92 % | 2 |
| Speedel Holding Ag | SPDHF.PK | Switzerland | | | | | | | % | % | 1 |
| Starpharma Holdings Limited | SPHRF.PK | Australia | | | | | | | % | % | 2 |
| Stem Cell Innovations Inc | SCLL.PK | United States | -1.00 | 2 | 0 | 1 | 0 | 1 | 0.00 % | 50.00 % | 0 |
| Stemcells Inc | STEM | United States | -0.04 | 49 | 7 | 8 | 16 | 17 | 34.04 % | 36.17 % | 2 |
| Supergen Inc | SUPG | United States | -0.20 | 97 | 10 | 16 | 29 | 40 | 34.11 % | 47.05 % | 12 |
| Synthetic Blood Intl Inc | SYBD.PK | United States | 0.00 | 1 | 0 | 0 | 0 | 0 | 0.00 % | 0.00 % | 0 |
| Targanta Therapeutics Corp | 3TT.BE | United States | 0.00 | 14 | 3 | 1 | 4 | 6 | 30.76 % | 46.15 % | 1 |
| Targeted Genetics Corp | TGEN | United States | 0.80 | 6 | 2 | 0 | 2 | 0 | 40.00 % | 0.00 % | 1 |
| Telik Inc | TELK | United States | -0.13 | 96 | 15 | 19 | 31 | 38 | 36.90 % | 45.23 % | 12 |
| Tercica Inc | TRCA | United States | 0.19 | 99 | 28 | 14 | 41 | 38 | 47.67 % | 44.18 % | 13 |
| Third Wave Technologies Inc | TWTI | United States | 0.46 | 159 | 62 | 34 | 87 | 47 | 60.00 % | 32.41 % | 14 |
| Torreypines Therapeutics Inc | TPTX | United States | 0.11 | 30 | 4 | 3 | 9 | 7 | 34.61 % | 26.92 % | 4 |
| Unigene Labs Inc | UUL.BE | United States | 0.33 | 3 | 0 | 0 | 1 | 0 | 33.33 % | 0.00 % | 0 |
| Vasogen Inc | VSGN | Canada | -0.06 | 17 | 2 | 2 | 5 | 6 | 33.33 % | 40.00 % | 2 |
| Vermillion Inc | CUL.BE | United States | -0.55 | 10 | 2 | 2 | 2 | 7 | 22.22 % | 77.77 % | 1 |
| Vertex Pharmaceuticals Inc | VRTX | United States | 0.22 | 301 | 47 | 26 | 132 | 97 | 53.44 % | 39.27 % | 54 |
| Vical | VICL | Belgium | 0.12 | 52 | 7 | 4 | 16 | 13 | 32.65 % | 26.53 % | 3 |
| Viragen Inc | VRAIU.PK | United States | 1.33 | 3 | 2 | 0 | 2 | 0 | 66.66 % | 0.00 % | 0 |
| Virexx Medical Corp | BCT.BE | Canada | -0.60 | 5 | 0 | 2 | 1 | 2 | 20.00 % | 40.00 % | 0 |
| Wuxi Pharmatech Cayman Inc | WX | Cayman Islands | 0.33 | 4 | 1 | 1 | 2 | 1 | 66.66 % | 33.33 % | 1 |
| Xoma Ltd | XOM.BE | Bermuda | -0.16 | 99 | 10 | 14 | 32 | 42 | 36.78 % | 48.27 % | 12 |
| Xpention Genetics Inc | XPNG.PK | United States | -2.00 | 1 | 0 | 1 | 0 | 1 | 0.00 % | 100.00 % | 0 |
| Xtl Biopharmaceuticals Ltd | XTLB | United States | 0.28 | 14 | 3 | 1 | 7 | 5 | 50.00 % | 35.71 % | 0 |
| Ziopharm Oncology Inc | WEK.BE | United States | 0.08 | 12 | 2 | 1 | 5 | 5 | 41.66 % | 41.66 % | 0 |